| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.34 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.46 | 0.05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |